Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave About Shockwave Medical, Inc.Shockwave is focused on developing and commercializing products ...
“The Shockwave L 6 catheter pushes the boundaries of what IVL can help physicians achieve for patients with severe peripheral arterial disease,” said Frank Arko, M.D., Chief of Vascular and ...
Shockwave Medical, Inc. SWAV recently commercially launched the Shockwave M5+ peripheral intravascular lithotripsy (“IVL”) catheter. Commercial availability of the product in Europe and the United ...
A minimally invasive treatment for calcified coronary artery disease called Shockwave Intravascular Lithotripsy is being performed at North Oaks Medical Center. The procedure, recently approved by the ...
SANTA CLARA, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
SANTA CLARA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback